• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼部网状细胞肉瘤的临床特征、实验室检查及生存情况

Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma.

作者信息

Freeman L N, Schachat A P, Knox D L, Michels R G, Green W R

机构信息

Wilmer Ophthalmological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21205.

出版信息

Ophthalmology. 1987 Dec;94(12):1631-9. doi: 10.1016/s0161-6420(87)33256-7.

DOI:10.1016/s0161-6420(87)33256-7
PMID:3323986
Abstract

The authors report 32 cases of histologically proven ocular reticulum cell sarcoma (RCS). Follow-up data are available for all patients. Twenty-six patients (81%) have died and the mean survival time was 20 months from the time of diagnosis of RCS. Diagnosis of ocular involvement was made by vitreous biopsy in 56% of cases, enucleation in 13%, and postmortem examination in 31%. The mean age at the time of diagnosis was 60 years. Central nervous system (CNS) involvement was present in 56% of patients, visceral involvement in 16%, and both CNS and visceral involvement in 6%. Isolated ocular disease occurred in 22% of patients. Results of head computed tomography (CT) and cerebrospinal fluid examination more often disclosed evidence of RCS than did body CT or nuclear medicine scans. Responses to treatment were variable, but prognosis for survival is poor.

摘要

作者报告了32例经组织学证实的眼网状细胞肉瘤(RCS)。所有患者均有随访数据。26例患者(81%)已死亡,自RCS诊断之时起平均生存时间为20个月。56%的病例通过玻璃体活检确诊眼部受累,13%通过眼球摘除术确诊,31%通过尸检确诊。诊断时的平均年龄为60岁。56%的患者存在中枢神经系统(CNS)受累,16%存在内脏受累,6%同时存在CNS和内脏受累。22%的患者为单纯眼部疾病。头部计算机断层扫描(CT)和脑脊液检查结果比身体CT或核医学扫描更常显示RCS的证据。治疗反应各不相同,但生存预后较差。

相似文献

1
Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma.眼部网状细胞肉瘤的临床特征、实验室检查及生存情况
Ophthalmology. 1987 Dec;94(12):1631-9. doi: 10.1016/s0161-6420(87)33256-7.
2
Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management.原发性眼内淋巴瘤(眼网状细胞肉瘤)的诊断与治疗
Ophthalmology. 1988 May;95(5):625-30. doi: 10.1016/s0161-6420(88)33145-3.
3
Ocular and central nervous system lymphoma: clinical features and diagnosis.眼部和中枢神经系统淋巴瘤:临床特征与诊断
Ocul Immunol Inflamm. 2000 Dec;8(4):243-50. doi: 10.1076/ocii.8.4.243.6463.
4
Ocular reticulum cell sarcoma. A case report.眼部网状细胞肉瘤。病例报告。
S Afr Med J. 1988 Jan 9;73(1):49-53.
5
[Non-Hodgkin lymphoma (a case of simultaneous ocular and orbital involvement)].
Vestn Oftalmol. 2015 May-Jun;131(3):82-89. doi: 10.17116/oftalma2015131382-89.
6
Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). Report of three cases.
J Neurosurg. 1984 Aug;61(2):369-74. doi: 10.3171/jns.1984.61.2.0369.
7
Intraocular reticulum cell sarcoma: diagnosis by choroidal biopsy.眼内网状细胞肉瘤:经脉络膜活检确诊
Br J Ophthalmol. 1987 Oct;71(10):748-52. doi: 10.1136/bjo.71.10.748.
8
Primary ocular adnexal lymphomas: a retrospective study of 25 patients.原发性眼附属器淋巴瘤:25例患者的回顾性研究
Leuk Lymphoma. 2013 Sep;54(9):2076-8. doi: 10.3109/10428194.2013.765567. Epub 2013 Feb 1.
9
[Oculocerebral malignant non-Hodgkin lymphoma. A report of 5 cases].[眼脑恶性非霍奇金淋巴瘤。5例报告]
Klin Monbl Augenheilkd. 1991 May;198(5):435-7. doi: 10.1055/s-2008-1046003.
10
Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.原发性玻璃体视网膜淋巴瘤的治疗策略:一项欧洲17中心协作研究
JAMA Ophthalmol. 2015 Feb;133(2):191-7. doi: 10.1001/jamaophthalmol.2014.4755.

引用本文的文献

1
Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.玻璃体液活检检测玻璃体内视网膜淋巴瘤的下一代测序:诊断潜力及基因型/表型相关性。
Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):27. doi: 10.1167/iovs.64.14.27.
2
Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience.原发性眼内淋巴瘤的诊断、治疗和预后:单中心真实世界临床经验。
Cancer Med. 2023 Apr;12(7):7911-7922. doi: 10.1002/cam4.5567. Epub 2023 Jan 31.
3
Rapidly Progressive Bilateral Vitreoretinal Lymphoma.
快速进展性双侧玻璃体视网膜淋巴瘤
Cureus. 2022 Nov 18;14(11):e31639. doi: 10.7759/cureus.31639. eCollection 2022 Nov.
4
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology.疑似眼内淋巴瘤患者的综合实验室诊断检查,包括流式细胞术、分子遗传学和细胞病理学。
Curr Oncol. 2022 Jan 31;29(2):766-776. doi: 10.3390/curroncol29020065.
5
Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.脉络膜血管结构的变化与玻璃体内甲氨蝶呤治疗后临床缓解相关的眼内细胞因子水平在眼内淋巴瘤中的变化。
PLoS One. 2021 Nov 23;16(11):e0260469. doi: 10.1371/journal.pone.0260469. eCollection 2021.
6
Challenges in the Diagnosis of Intraocular Lymphoma.眼内淋巴瘤诊断的挑战。
Turk J Ophthalmol. 2021 Oct 26;51(5):317-325. doi: 10.4274/tjo.galenos.2021.50607.
7
Vitreoretinal Lymphoma.玻璃体视网膜淋巴瘤
Cancers (Basel). 2021 Aug 4;13(16):3921. doi: 10.3390/cancers13163921.
8
Radiotherapy as Salvage Treatment in Intraocular Lymphoma: A Case Report.放射治疗作为眼内淋巴瘤的挽救性治疗:一例报告
Case Rep Oncol. 2021 Mar 1;14(1):184-189. doi: 10.1159/000512216. eCollection 2021 Jan-Apr.
9
Identification of Prognostic Markers in Patients with Primary Vitreoretinal Lymphoma by Clustering Analysis Using Clinical Data.利用临床数据通过聚类分析鉴定原发性玻璃体视网膜淋巴瘤患者的预后标志物
J Clin Med. 2020 Jul 20;9(7):2298. doi: 10.3390/jcm9072298.
10
Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.原发性玻璃体视网膜淋巴瘤:患病率、影响及管理挑战
Clin Ophthalmol. 2019 Feb 14;13:353-364. doi: 10.2147/OPTH.S159014. eCollection 2019.